NCT00773474 2016-02-18
Lonafarnib in Metastatic Breast Cancer
Hoosier Cancer Research Network
Phase 2 Terminated
Clinical Trials
5 trialsNCT00081510 2015-04-15
Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT00539968 2015-02-05
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 1/2 Terminated
NCT00288444 2012-12-18
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Emory University
Phase 1 Terminated
NCT00068757 2012-09-12
Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed